Population
Human rhinoviruses (in vitro model)
Comparison
Anti-viral capsid binders vs Native virus (without antivirals)
Design
Preclinical
Authors
Loading...
May guide capsid binder development; leaves open clinical translation from animal models.
Antiviral capsid binders stabilize human rhinoviruses against thermal denaturation, disrupting the normal kinetically well-defined pathway of viral decay.
Okun et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: